Literature DB >> 23415048

A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy.

Akila N Viswanathan1, Jackie Szymonifka, Clare M Tempany-Afdhal, Desmond A O'Farrell, Robert A Cormack.   

Abstract

PURPOSE: To present outcome and toxicity results of the first real-time intraoperative MRI-guided interstitial approach to gynecologic cancer. METHODS AND MATERIALS: From February 2004 to December 2006, 25 patients with gynecologic malignancies were enrolled and treated in a prospective clinical trial of real-time MRI-guided interstitial brachytherapy. This was followed by a confirmatory CT imaging scan. Statistical analyses included Kaplan-Meier estimates for overall and relapse-free survival.
RESULTS: MRI visualization of needles during placement permitted accurate placement with no inadvertent insertions. This prevented unnecessary normal-tissue perforation as confirmed by CT simulation. With a mean followup of 3.8 years (range, 2-6.8), 1-, 2-, and 3-year overall survival rates were 80%, 60% and 43%, respectively; corresponding relapse-free survival rates were 79%, 65%, and 59%, respectively. Actuarial acute toxicity rates for any grade were 0% at 0-14 days and 80% (all grade 1) at 14-90 days. Long-term (>180 days) actuarial toxicity rates were 8% gastrointestinal, 4% bladder and 4% vaginal.
CONCLUSIONS: Real-time MRI guidance during insertion of interstitial needles followed by 3D-planning maximized opportunities for tumor targeting and sparing of normal tissues. Although image guidance requires additional anesthesia time, clinical outcomes indicate potential for a successful reduction in toxicity using 3D image-guided in addition to 3D image-planned brachytherapy.
Copyright © 2013 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23415048     DOI: 10.1016/j.brachy.2012.08.006

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  24 in total

1.  Novel use of a hydrogel spacer permits reirradiation in otherwise incurable recurrent gynecologic cancers.

Authors:  Akila N Viswanathan; Antonio L Damato; Paul L Nguyen
Journal:  J Clin Oncol       Date:  2013-10-21       Impact factor: 44.544

2.  Comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix.

Authors:  Sophia C Kamran; Matthias M Manuel; Linda P Cho; Antonio L Damato; Ehud J Schmidt; Clare Tempany; Robert A Cormack; Akila N Viswanathan
Journal:  Gynecol Oncol       Date:  2017-03-18       Impact factor: 5.482

3.  A radiopaque polymer hydrogel used as a fiducial marker in gynecologic-cancer patients receiving brachytherapy.

Authors:  Ryan J Bair; Eric Bair; Akila N Viswanathan
Journal:  Brachytherapy       Date:  2015-10-23       Impact factor: 2.362

4.  Validation of catheter segmentation for MR-guided gynecologic cancer brachytherapy.

Authors:  Guillaume Pernelle; Alireza Mehrtash; Lauren Barber; Antonio Damato; Wei Wang; Ravi Teja Seethamraju; Ehud Schmidt; Robert A Cormack; Williams Wells; Akila Viswanathan; Tina Kapur
Journal:  Med Image Comput Comput Assist Interv       Date:  2013

5.  Prospective Clinical Implementation of a Novel Magnetic Resonance Tracking Device for Real-Time Brachytherapy Catheter Positioning.

Authors:  Jose de Arcos; Ehud J Schmidt; Wei Wang; Junichi Tokuda; Kamal Vij; Ravi T Seethamraju; Antonio L Damato; Charles L Dumoulin; Robert A Cormack; Akila N Viswanathan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-06-07       Impact factor: 7.038

6.  Real-time active MR-tracking of metallic stylets in MR-guided radiation therapy.

Authors:  Wei Wang; Charles L Dumoulin; Akila N Viswanathan; Zion T H Tse; Alireza Mehrtash; Wolfgang Loew; Isaiah Norton; Junichi Tokuda; Ravi T Seethamraju; Tina Kapur; Antonio L Damato; Robert A Cormack; Ehud J Schmidt
Journal:  Magn Reson Med       Date:  2014-06-05       Impact factor: 4.668

7.  3-T MR-guided brachytherapy for gynecologic malignancies.

Authors:  Tina Kapur; Jan Egger; Antonio Damato; Ehud J Schmidt; Akila N Viswanathan
Journal:  Magn Reson Imaging       Date:  2012-08-13       Impact factor: 2.546

Review 8.  Magnetic resonance image guided brachytherapy.

Authors:  Kari Tanderup; Akila N Viswanathan; Christian Kirisits; Steven J Frank
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

9.  Characterizing gradient echo signal decays in gynecologic cancers at 3T using a Gaussian augmentation of the monoexponential (GAME) model.

Authors:  Pelin A Ciris; Mukund Balasubramanian; Antonio L Damato; Ravi T Seethamraju; Clare M Tempany-Afdhal; Robert V Mulkern; Akila N Viswanathan
Journal:  J Magn Reson Imaging       Date:  2016-03-12       Impact factor: 4.813

10.  Evaluation of an active magnetic resonance tracking system for interstitial brachytherapy.

Authors:  Wei Wang; Akila N Viswanathan; Antonio L Damato; Yue Chen; Zion Tse; Li Pan; Junichi Tokuda; Ravi T Seethamraju; Charles L Dumoulin; Ehud J Schmidt; Robert A Cormack
Journal:  Med Phys       Date:  2015-12       Impact factor: 4.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.